Researchers from think tank First Longevity today published a new report on ovarian aging, calling for greater investment and research into science and technology to extend fertility and delay the menopause.
As part of the report, the researchers conducted a YouGov study of more than 1,000 women in the UK, which revealed that 32% of those aged 18-44 would take an intervention (a drug or other form of treatment) if it would delay their menopause and extend their fertility. Based on figures from the Office for National Statistics, this is equivalent to 3.6 million women in the UK.
Women’s life expectancy has increased by as much 30 years since 1900, but the onset of menopause has only been pushed back by four years. Ovaries are one of the earliest-aging organs in the body and drive the subsequent aging of multiple organs in women’s bodies.
During menopause, the loss of estrogen due to ovarian failure increases several health risks for women including cardiovascular disease, osteoporosis and Alzheimer’s. The NHS Long Term Plan states that British women may live up to 34% of their lives in poor health, which leads to significant societal and economic impacts.